Author Question: The nurse instructs a patient taking oral iron preparations about which potential adverse effect? ... (Read 74 times)

bobbysung

  • Hero Member
  • *****
  • Posts: 519
The nurse instructs a patient taking oral iron preparations about which potential adverse effect?
 
  A) Clay-colored stools
  B) Hypotension
  C) Constipation
  D) Frequent flatus

Question 2

What medication, given with aprepitant (Emend), is used to effectively manage chemotherapy-induced emesis?
 
  A) Bonamine
  B) Dexamethasone
  C) Phenergan
  D) Ativan



honnalora

  • Sr. Member
  • ****
  • Posts: 325
Answer to Question 1

C
Feedback:
The most common adverse effects associated with oral iron supplements are related to direct GI irritation (e.g., GI upset, anorexia, nausea, vomiting, diarrhea, dark stools, and constipation). Oral iron supplements do not cause hypotension, clay-colored stools, or frequent flatus.

Answer to Question 2

B
Feedback:
Aprepitant acts directly in the central nervous system to block receptors associated with nausea and vomiting with little to no effect on serotonin and dopamine levels, nor corticosteroid receptors. It is approved for use in treating nausea and vomiting associated with highly emetogenic antineoplastic chemotherapy, including cisplatin therapy. It is given orally, in combination with dexamethasone. Bonamine, Phenergan, and Ativan are not used in conjunction with Emend.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question


 

Did you know?

According to the American College of Allergy, Asthma & Immunology, more than 50 million Americans have some kind of food allergy. Food allergies affect between 4 and 6% of children, and 4% of adults, according to the CDC. The most common food allergies include shellfish, peanuts, walnuts, fish, eggs, milk, and soy.

Did you know?

In most climates, 8 to 10 glasses of water per day is recommended for adults. The best indicator for adequate fluid intake is frequent, clear urination.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

More than 2,500 barbiturates have been synthesized. At the height of their popularity, about 50 were marketed for human use.

Did you know?

In most cases, kidneys can recover from almost complete loss of function, such as in acute kidney (renal) failure.

For a complete list of videos, visit our video library